These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


749 related items for PubMed ID: 21256164

  • 1. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD.
    Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A, Milner K, Gupta A, Lopaschuk GD.
    Curr Pharm Des; 2015 Jul; 21(25):3654-64. PubMed ID: 26166604
    [Abstract] [Full Text] [Related]

  • 4. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S, Biagioli B.
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [Abstract] [Full Text] [Related]

  • 5. The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia.
    Lopaschuk GD, Saddik M.
    Mol Cell Biochem; 1992 Oct 21; 116(1-2):111-6. PubMed ID: 1480139
    [Abstract] [Full Text] [Related]

  • 6. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR, Cheng JF, Stanley WC, Barr R, Chandler MP, Brown S, Wallace D, Arrhenius T, Harmon C, Yang G, Nadzan AM, Lopaschuk GD.
    Circ Res; 2004 May 14; 94(9):e78-84. PubMed ID: 15105298
    [Abstract] [Full Text] [Related]

  • 7. Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis.
    Folmes CD, Clanachan AS, Lopaschuk GD.
    Curr Atheroscler Rep; 2005 Feb 14; 7(1):63-70. PubMed ID: 15683605
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Calcium regulation of glycolysis, glucose oxidation, and fatty acid oxidation in the aerobic and ischemic heart.
    Schönekess BO, Brindley PG, Lopaschuk GD.
    Can J Physiol Pharmacol; 1995 Nov 14; 73(11):1632-40. PubMed ID: 8789418
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischaemic heart failure.
    Ho KL, Karwi QG, Wang F, Wagg C, Zhang L, Panidarapu S, Chen B, Pherwani S, Greenwell AA, Oudit GY, Ussher JR, Lopaschuk GD.
    Cardiovasc Res; 2024 Sep 02; 120(10):1126-1137. PubMed ID: 38691671
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.
    Fillmore N, Mori J, Lopaschuk GD.
    Br J Pharmacol; 2014 Apr 02; 171(8):2080-90. PubMed ID: 24147975
    [Abstract] [Full Text] [Related]

  • 16. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart.
    Sambandam N, Lopaschuk GD.
    Prog Lipid Res; 2003 May 02; 42(3):238-56. PubMed ID: 12689619
    [Abstract] [Full Text] [Related]

  • 17. Calcium improves mechanical function and carbohydrate metabolism following ischemia in isolated Bi-ventricular working hearts from immature rabbits.
    Itoi T, Lopaschuk GD.
    J Mol Cell Cardiol; 1996 Jul 02; 28(7):1501-14. PubMed ID: 8841937
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.